FDG-PET/CT Accreditation
NEMA Phantom Video
This Video explains the phantom measurement required to attain and maintain PET/CT EARL Accreditation.
In March 2015 the EANM updated the “FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging: version 2.0.” in the European Journal of Nuclear Medicine and Molecular Imaging (EJNMMI). On the basis of this guideline, EARL has set up the EARL FDG-PET/CT accreditation programme, which was launched in July 2010, to help imaging sites meet the standard requirements indicated in the guideline. The EARL FDG-PET/CT accreditation programme is endorsed by the European Organisation for Research and Treatment of Cancer (EORTC) Imaging Group.
Why it is of importance to seek EARL FDG PET/CT accreditation and how you will benefit:
-
Independent quality control/ assurance by a fully authorised body. EARL´s know-how is based on imaging experts with a worldwide reputation and a global leading role in PET/CT research, who provide advice within the programme and monitor its development.
-
Comparable scanner performance across multiple sites through harmonisation of the acquisition and interpretation of PET/CT scans (reducing inter-/intra-institute variability in SUV results; providing lower/upper limits of recovery coefficients; calibration factor within +/-10%): results can be compared, exchanged and combined.
-
Accurate, reproducible and quantitative assessment enabled through standardisation of methodology, including patient preparation, scan acquisition, image processing and analysis.
-
Essential quality assurance in daily clinical practice as well as high eligibility is a participant in multicentre trials.
-
Accredited centres of excellence strengthen their status via publication on the EARL website, a signet sticker and an accreditation certificate.
For further information on the rationale, please refer to the presentation of R. Boellaard, scientific leader of the accreditation programme and watch the video on youtube.
COST OF ACCREDIATION
To gain EARL FDG-PET/CT accreditation, sites are required to regularly (cross-)calibrate their PET/CT scanner and to regularly perform image quality control (QC) experiments, which are described in detail in the above-mentioned guideline. After performance of these QC experiments, the department will be able to compare, exchange and combine FDG-PET/CT findings.
The charge for the EARL FDG-PET/CT accreditation programme is € 1,000 net per calendar year/per centre/per scanner – which covers the costs for the initial accreditation process and maintaining the status of an EANM/EARL accredited centre for PET/CT.
We are pleased to inform you about a special discount system for the annual EARL FDG-PET/CT accreditation fee.
From 2015 on, EARL is offering a discount on the accreditation fee, which depends on the number of PET/CT scanners participating per country. Every participating PET/CT scanner stands for a reduction of 1% of the accreditation fee, however, there is a maximum reduction of 25% per country. This reduction will be granted to all participating scanners of the respective country. The reduction for 2016 will be granted for scanners that were part of the programme before September 10, 2015.
In 2010, EARL has successfully started the accreditation process in 11 European sites, which also allowed their participation in an EORTC clinical study in which imaging is involved. EARL has gained valuable experience through accrediting these centres and used this know-how to further improve its accreditation documents and procedures. Based on the results of this pilot study, a redefinition (improvement) of the SUV recoveries was performed. See "accreditation specifications".
EARL is very keen on enhancing the quality standard of PET/CT sites for both daily use and for multicentre trials and will continue to expand the accreditation to more PET/CT centres in Europe and beyond. Please see the statistics (as of July 2014) which show the immens increase of sites participating in the accreditation programme.
For further information concerning the benefits and services of the accreditation programme please refer to the general information sheet as well as to the information sheet for CROs and pharmaceutical companies. If you are interested in the EARL FDG-PET/CT accreditation programme, please contact EARL (earl@eanm.org).
You can join the EARL FDG-PET/CT accreditation program each quarter of 2017:
Quarter 1
Deadline payment of accreditation fee: 4.1.2017
Deadline submission of online questionnaire: 25.1.2017
Deadline submission of QC documents: 16.2.2017
Quarter 2
Deadline payment of accreditation fee: 4.4.2017
Deadline submission of online questionnaire: 25.4.2017
Deadline submission of QC documents: 16.5.2017
Quarter 3
Deadline payment of accreditation fee: 4.7.2017
Deadline submission of online questionnaire: 25.7.2017
Deadline submission of QC documents: 16.8.2017
Quarter 4
Deadline payment of accreditation fee: 4.10.2017
Deadline submission of online questionnaire: 25.10.2017
Deadline submission of QC documents: 16.11.2017
>> print article